When comparing HC subjects to medication-free TRD subjects at baseline, TRD patients demonstrated significantly elevated levels of IL-6 after Bonferroni correction for multiple comparisons (Figure 1a—raw P=0.004; corrected P=0.01). The gene discussed is IL6; the disease is treatment resistant depression.